Clinical Trials Directory

Trials / Completed

CompletedNCT04508556

Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study

Performance Assessment of SARS-CoV-2 Detection Through Analysis of Exhaled Breath Aerosols

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Owlstone Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

The primary aim of this study is to investigate the performance of Breath Biopsy RD for the detection of SARS-CoV-2 in both a clinical and at home setting.

Detailed description

This study aims to evaluate Owlstone Medical's Breath Biopsy RD Collectors for the detection of SARS-CoV-2 infection. These single use disposable breath capture devices can be used independently by individuals and shipped to be analysed in a central lab for the presence of SARS-CoV-2 using established existing PCR assays available in any reference lab. The aerosol collectors furthermore directly sample exhaled breath aerosols. As such they directly sample the primary transmission route for the virus. This could result in a higher rate of retrieval of viral RNA in infected individuals thereby increasing the sensitivity of the applied PCR assay. This is underpinned by the fact that CT abnormalities in the lower airways appear to occur prior to upper respiratory tract samples becoming positive in cases suffering from nCOVID19, suggesting lower airway viral loads could be higher. Combined, this could enable more widespread access to diagnostics, reduce the need for repeat testing, decrease the need for healthcare professionals to perform diagnostic tests and reduce cross-contamination risk.

Conditions

Interventions

TypeNameDescription
DEVICEBreath Biopsy face masks with removable filters and fitted PVA stripDevice developed for collection of breath samples
DIAGNOSTIC_TESTNasopharyngeal swabIs a method for collecting a clinical test sample of nasal secretions from the back of the nose and throat.
DIAGNOSTIC_TESToropharyngeal swabsIs a method for collecting a clinical test sample from the back of the throat.

Timeline

Start date
2020-09-30
Primary completion
2020-12-19
Completion
2020-12-19
First posted
2020-08-11
Last updated
2021-04-01

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04508556. Inclusion in this directory is not an endorsement.